Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study
Emma L. van der Ende, Lieke Meeter, Jackie M. Poos, et al.
The Lancet Neurology (2019) Vol. 18, Iss. 12, pp. 1103-1111
Open Access | Times Cited: 158

Showing 1-25 of 158 citing articles:

Blood neurofilament light: a critical review of its application to neurologic disease
Christian Barro, Tanuja Chitnis, Howard L. Weiner
Annals of Clinical and Translational Neurology (2020) Vol. 7, Iss. 12, pp. 2508-2523
Open Access | Times Cited: 204
Neurofilament Proteins as Biomarkers to Monitor Neurological Diseases and the Efficacy of Therapies
Aidong Yuan, Ralph A. Nixon
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 200
Serum markers glial fibrillary acidic protein and neurofilament light for prognosis and monitoring in cognitively normal older people: a prospective memory clinic-based cohort study
Inge M.W. Verberk, Malika B Laarhuis, Karlijn A. van den Bosch, et al.
The Lancet Healthy Longevity (2021) Vol. 2, Iss. 2, pp. e87-e95
Open Access | Times Cited: 149
Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations
Bradley F. Boeve, Adam L. Boxer, Fiona Kumfor, et al.
The Lancet Neurology (2022) Vol. 21, Iss. 3, pp. 258-272
Open Access | Times Cited: 139
Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5–90 years
Joel Simrén, Ulf Andréasson, Johan Gobom, et al.
Brain Communications (2022) Vol. 4, Iss. 4
Open Access | Times Cited: 114
Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Federico Verde, Markus Otto, Vincenzo Silani
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 106
Temporal order of clinical and biomarker changes in familial frontotemporal dementia
Adam M. Staffaroni, Melanie Quintana, Barbara Wendelberger, et al.
Nature Medicine (2022) Vol. 28, Iss. 10, pp. 2194-2206
Open Access | Times Cited: 87
Frontotemporal lobar degeneration
Murray Grossman, William W. Seeley, Adam L. Boxer, et al.
Nature Reviews Disease Primers (2023) Vol. 9, Iss. 1
Closed Access | Times Cited: 69
Blood Biomarkers in Neurodegenerative Diseases
Daniel Alcolea, Michal Schnaider Beeri, Julio C. Rojas, et al.
Neurology (2023) Vol. 101, Iss. 4, pp. 172-180
Closed Access | Times Cited: 46
Fluid biomarkers for amyotrophic lateral sclerosis: a review
Katherine E. Irwin, Udit Sheth, Philip C. Wong, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 29
Dynamics and prognostic value of serum neurofilament light chain in Guillain-Barré syndrome
Sander J. van Tilburg, Charlotte E. Teunissen, Carolien C H M Maas, et al.
EBioMedicine (2024) Vol. 102, pp. 105072-105072
Open Access | Times Cited: 18
Amyotrophic lateral sclerosis caused by hexanucleotide repeat expansions in C9orf72: from genetics to therapeutics
Sarah Mizielinska, Guillaume M. Hautbergue, Tania F. Gendron, et al.
The Lancet Neurology (2025) Vol. 24, Iss. 3, pp. 261-274
Closed Access | Times Cited: 3
Frontotemporal dementia. How to deal with its diagnostic complexity?
Annibale Antonioni, Emanuela Maria Raho, Enrico Granieri, et al.
Expert Review of Neurotherapeutics (2025)
Closed Access | Times Cited: 2
Blood biomarkers for clinical applications in Alzheimer's disease: A narrative review
Huijun Li, Zhe Wang
NeuroMarkers. (2025) Vol. 2, Iss. 2, pp. 100078-100078
Open Access | Times Cited: 2
Diagnostic and prognostic value of serum NfL and p-Tau181in frontotemporal lobar degeneration
Alberto Benussi, Thomas K. Karikari, Nicholas J. Ashton, et al.
Journal of Neurology Neurosurgery & Psychiatry (2020) Vol. 91, Iss. 9, pp. 960-967
Open Access | Times Cited: 127
Plasma Tau and Neurofilament Light in Frontotemporal Lobar Degeneration and Alzheimer Disease
Ignacio Illán‐Gala, Alberto Lleó, Anna Karydas, et al.
Neurology (2020) Vol. 96, Iss. 5
Open Access | Times Cited: 115
Fluid biomarkers in frontotemporal dementia: past, present and future
Imogen J. Swift, Aitana Sogorb‐Esteve, Carolin Heller, et al.
Journal of Neurology Neurosurgery & Psychiatry (2020) Vol. 92, Iss. 2, pp. 204-215
Open Access | Times Cited: 102
Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and mice
Carlo Wilke, Eva Haas, Kathrin Reetz, et al.
EMBO Molecular Medicine (2020) Vol. 12, Iss. 7
Open Access | Times Cited: 89
Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington’s disease
Filipe B. Rodrigues, Lauren M. Byrne, Rosanna Tortelli, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 574
Open Access | Times Cited: 88
Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration
Julio C. Rojas, Ping Wang, Adam M. Staffaroni, et al.
Neurology (2021) Vol. 96, Iss. 18
Open Access | Times Cited: 81
Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases
Michael Benatar, Joanne Wuu, Caroline McHutchison, et al.
Brain (2021) Vol. 145, Iss. 1, pp. 27-44
Open Access | Times Cited: 77
Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations
Meixiang Huang, Erica Modeste, Eric B. Dammer, et al.
Acta Neuropathologica Communications (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 75
Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia
Emma L. van der Ende, Mei-Fang Xiao, Desheng Xu, et al.
Journal of Neurology Neurosurgery & Psychiatry (2020) Vol. 91, Iss. 6, pp. 612-621
Open Access | Times Cited: 73
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment
Lorenzo Gaetani, Federico Paolini Paoletti, G. Bellomo, et al.
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 12, pp. 1023-1037
Closed Access | Times Cited: 73
Body Fluid Biomarkers for Alzheimer’s Disease—An Up-To-Date Overview
Adrian Bălașa, Cristina Chircov, Alexandru Mihai Grumezescu
Biomedicines (2020) Vol. 8, Iss. 10, pp. 421-421
Open Access | Times Cited: 72
Page 1 - Next Page

Scroll to top